The FDA has granted 510(k) premarket clearance to the Soberlink Breathalyzer for use in a medical setting. With this clearance, health care providers will be able to remotely measure alcohol in human breath for the purpose of aiding in the detection and monitoring of alcohol consumption in those who suffer from alcohol-use disorders.
Read More
The global point-of-care (POC) diagnostics market is expected to reach $36.96 billion by 2021, at a compound annual growth rate (CAGR) of 9.8% from 2016 to 2021, according to a new report. Key factors such as prevalence of lifestyle and infectious diseases and the increasing inclination toward home healthcare across the globe are driving market growth globally.
Read MoreAgfa HealthCare has joined forces with 15 health systems, academic medical centers, ambulatory radiology providers, and imaging technology companies in the Watson Health global medical imaging collaborative. The health care IT vendor and its collaborators will focus on using cognitive imaging to care for patients with breast, lung, and other cancers, in addition to heart disease, diabetes, eye health, and heart disease and stroke.
Read MoreAbbott and St Jude Medical have announced a deal for Abbott to acquire St Jude Medical, strengthening Abbott’s position in the cardiovascular, diabetes, vision, and neuromodulation markets. The new company will occupy the first or second position across the cardiovascular device markets, with combined annual sales totaling approximately $8.7 billion.
Read MoreSentrian, the maker of a remote patient intelligence platform designed to reduce preventable hospitalization in chronic disease patients, has received clearance from the FDA to immediately begin marketing its solution in the US.
Read More